Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Lipoprotein Disorder”

124 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 124 results

Post-approval studies (Phase 4)Study completedNCT00079638
What this trial is testing

Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL

Who this might be right for
DyslipidemiaCoronary Heart DiseaseAtherosclerosis+2 more
Kos Pharmaceuticals 300
Not applicableEnded earlyNCT05629767
What this trial is testing

Tracking of Lipid Lowering Therapy in Jordan

Who this might be right for
DyslipidemiasAtherosclerotic Cardiovascular Disease
Jordan Collaborating Cardiology Group 1,000
Large-scale testing (Phase 3)Study completedNCT01323153
What this trial is testing

Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)

Who this might be right for
Coronary Heart Disease
Hoffmann-La Roche 300
Post-approval studies (Phase 4)Study completedNCT00442845
What this trial is testing

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

Who this might be right for
Coronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 2,080
Not applicableStudy completedNCT00931320
What this trial is testing

Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients

Who this might be right for
Dyslipidemias
AstraZeneca 3,000
Testing effectiveness (Phase 2)Study completedNCT00529542
What this trial is testing

A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol

Who this might be right for
Polycystic Ovary Syndrome
Milton S. Hershey Medical Center 20
Not applicableStudy completedNCT05844566
What this trial is testing

OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.

Who this might be right for
Acute Coronary SyndromeMyocardial Infarction
Imperial College London 1,139
Large-scale testing (Phase 3)Study completedNCT00092612
What this trial is testing

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)

Who this might be right for
HypercholesterolemiaCoronary Disease
Organon and Co 372
Large-scale testing (Phase 3)Active Not RecruitingNCT04765657
What this trial is testing

Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Hypercholesterolemia
Novartis Pharmaceuticals 345
Not applicableStudy completedNCT00386971
What this trial is testing

Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART

Who this might be right for
HyperlipidemiaHIV Infections
University of California, Davis 13
Post-approval studies (Phase 4)Looking for participantsNCT07839741
What this trial is testing

LDL Cholesterol Reduction Following Ezetimibe Initiation

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Cardiovascular RiskLDL Cholesterol
Universidade do Porto 100
Very early researchNot Yet RecruitingNCT06293729
What this trial is testing

Safety and Efficacy Study of NGGT006 in Refractory Hypercholesterolemia Patients

Who this might be right for
Refractory HypercholesterolemiaFamilial Hypercholesterolemia
Suzhou Municipal Hospital 9
Post-approval studies (Phase 4)Study completedNCT00249938
What this trial is testing

Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.

Who this might be right for
HyperlipidemiaDyslipidemia
University of Colorado, Denver 60
Not applicableStudy completedNCT01840683
What this trial is testing

HELP Therapy for Dry AMD

Who this might be right for
Non-exudative (Dry) Age-related Macular Degeneration (AMD)
B.Braun Avitum AG 22
Post-approval studies (Phase 4)Study completedNCT00645151
What this trial is testing

The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol

Who this might be right for
Dyslipidemias
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 512
Not applicableStudy completedNCT01381679
What this trial is testing

Effect of Ezetimibe Treatment on Low-density Lipoprotein Cholesterol (LDL-C) Levels in Participants With Coronary Heart Disease (CHD) Already Treated With a Statin (MK-0653A-205 AM1)

Who this might be right for
Hypercholesterolemia
Organon and Co 1,682
Large-scale testing (Phase 3)Study completedNCT02189837
What this trial is testing

Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody

Who this might be right for
Primary Hyperlipidemia and Mixed Dyslipidemia
Amgen 89
Not applicableEnded earlyNCT01447901
What this trial is testing

Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies

Who this might be right for
Hyperlipoproteinemia Type I
Amsterdam Molecular Therapeutics 19
Post-approval studies (Phase 4)Study completedNCT00932620
What this trial is testing

Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL)

Who this might be right for
Hypercholesterolemia
University of Ioannina 100
Testing effectiveness (Phase 2)Study completedNCT02048059
What this trial is testing

ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Angiochem Inc 72
Next Page